Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2020 Filed Jun 10, 2020 22:38 UTC |
Cohen Fred EDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035678 · doc4.xml · derivative · entry 1 Cohen Fred E · CIK 0001339358 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:36 UTC |
BUTITTA CYNTHIA MDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035677 · doc4.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:35 UTC |
Belldegrun ArieDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-20-035676 · doc4.xml · derivative · entry 1 Belldegrun Arie · CIK 0001296549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 18:31 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034672 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,083 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on December 7, 2017 representing 12,500 ordinary shares. 33.33% of the RSUs vested on December 4, 2018 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 18:31 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 349 | $27.51 | $9,601.97 |
DisclosureSEC source: 0001209191-20-034672 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,404 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 18:31 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-034672 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| June 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · derivative · entry 8 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,341 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| June 03, 2020 Filed Jul 12, 2021 22:59 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046344 · doc4a.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On December 4, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 61,652 shares vested on May 3, 2020. In fact, the shares vested monthly from June 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 20, 2020 Filed May 20, 2020 20:44 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030900 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,208 Underlying: Ordinary Shares · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on August 20, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| May 20, 2020 Filed May 20, 2020 20:44 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 358 | $25.07 | $8,975.06 |
DisclosureSEC source: 0001209191-20-030900 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,079 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| May 20, 2020 Filed May 20, 2020 20:44 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 1,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-030900 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| May 12, 2020 Filed May 14, 2020 17:07 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 35,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029079 · doc4.xml · derivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,148 Underlying: Ordinary Shares · 35,229 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. The remaining unvested restricted stock units will vest at a rate of 2.778% in equal monthly installments thereafter. Read SEC document |
| May 12, 2020 Filed May 14, 2020 17:07 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 35,229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029079 · doc4.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the settlement of restricted stock units that vested from February 3, 2020 through May 3, 2020 through the issuance of ordinary shares. Read SEC document |
| May 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · derivative · entry 8 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,148 Underlying: Ordinary Shares · 8,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| May 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,808 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · nonDerivative · entry 4 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 17:53 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 70 | $24.35 | $1,704.50 |
DisclosureSEC source: 0001209191-20-025904 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,711 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 17:51 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 141 | $24.35 | $3,433.35 |
DisclosureSEC source: 0001209191-20-025903 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,396 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 17:43 UTC |
Mullennix StephenChief Operating Officer
|
SaleOrdinary Shares | 145 | $24.35 | $3,530.75 |
DisclosureSEC source: 0001209191-20-025893 · doc4.xml · nonDerivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,084 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| April 26, 2020 Filed Apr 28, 2020 17:53 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025904 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459 Underlying: Ordinary Shares · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 2,500 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| April 26, 2020 Filed Apr 28, 2020 17:53 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 208 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025904 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| April 26, 2020 Filed Apr 28, 2020 17:51 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025903 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,917 Underlying: Ordinary Shares · 417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on January 26, 2019 representing 5,000 ordinary shares. 33.33% of the RSUs vested on January 26, 2020 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| April 26, 2020 Filed Apr 28, 2020 17:51 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025903 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| April 26, 2020 Filed Apr 28, 2020 17:43 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025893 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,917 Underlying: Ordinary Shares · 417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. F3 · derivative.expiration_date: The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter. Read SEC document |
| April 26, 2020 Filed Apr 28, 2020 17:43 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionOrdinary Shares | 417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025893 · doc4.xml · nonDerivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| April 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · derivative · entry 7 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,956 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| April 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · nonDerivative · entry 3 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 04, 2020 Filed Mar 4, 2020 22:28 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016275 · doc4.xml · derivative · entry 3 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · kind: The transaction reported herein was matchable under Section 16(b) of the Securities and Exchange Act of 1934, to the extent of 345 shares, with the reporting person's purchase of 1,960 ordinary shares of the Issuer at a price of $28.17 per share on November 19, 2019. The reporting person has paid to the Issuer $458.85, representing the full amount of the profit realized in connection with the short-swing transaction. F4 · derivative.exercise_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of three years. F4 · derivative.expiration_date: On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of three years. Read SEC document |
| March 04, 2020 Filed Mar 4, 2020 22:28 UTC |
Schoenberg MarkChief Medical Officer
|
Tax withholdingOrdinary Shares | 345 | $29.50 | $10,177.50 |
DisclosureSEC source: 0001209191-20-016275 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,573 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| March 04, 2020 Filed Mar 4, 2020 22:28 UTC |
Schoenberg MarkChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-016275 · doc4.xml · nonDerivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| March 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · derivative · entry 6 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,763 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| March 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · nonDerivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:53 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-012017 · doc4.xml · derivative · entry 3 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,249 Underlying: Ordinary Shares · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F4 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. F4 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on July 19, 2018 representing 12,500 ordinary shares. 33.33% of the RSUs vested on August 20, 2019 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:53 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 360 | $29.68 | $10,684.80 |
DisclosureSEC source: 0001209191-20-012017 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,120 F3 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:53 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-012017 · doc4.xml · nonDerivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,480 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. F2 · balance_after: This amount includes 1,000 shares reported on Reporting Person's Form 3 that were omitted from subsequent Form 4 filings. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:33 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009943 · doc4.xml · derivative · entry 3 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,037 Underlying: Ordinary Shares · 1,759 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. F3 · derivative.expiration_date: The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:33 UTC |
Mullennix StephenChief Operating Officer
|
SaleOrdinary Shares | 612 | $28.04 | $17,160.48 |
DisclosureSEC source: 0001209191-20-009943 · doc4.xml · nonDerivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,812 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 19:33 UTC |
Mullennix StephenChief Operating Officer
|
Exercise / conversionOrdinary Shares | 1,759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-009943 · doc4.xml · nonDerivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Read SEC document |
| February 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · derivative · entry 5 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,570 Underlying: Ordinary Shares · 8,807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F3 · derivative.exercise_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. F3 · derivative.expiration_date: On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years. Read SEC document |
| February 03, 2020 Filed Jul 12, 2021 22:57 UTC Amendment |
Barrett Elizabeth A.Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 8,807 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-046340 · doc4a.xml · nonDerivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:38 UTC |
Schoenberg MarkChief Medical Officer
|
GrantRestricted stock unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006210 · doc4.xml · derivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F3 · derivative.expiration_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:38 UTC |
Schoenberg MarkChief Medical Officer
|
GrantStock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $29.41 | $0.00 |
DisclosureSEC source: 0001209191-20-006210 · doc4.xml · derivative · entry 1 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F1 · derivative.expiration_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:40 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006212 · doc4.xml · derivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 6,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F3 · derivative.expiration_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:40 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
GrantStock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $29.41 | $0.00 |
DisclosureSEC source: 0001209191-20-006212 · doc4.xml · derivative · entry 1 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F1 · derivative.expiration_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:39 UTC |
Mullennix StephenChief Operating Officer
|
GrantRestricted stock unit · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006211 · doc4.xml · derivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Ordinary Shares · 3,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F3 · derivative.expiration_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:39 UTC |
Mullennix StephenChief Operating Officer
|
GrantStock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $29.41 | $0.00 |
DisclosureSEC source: 0001209191-20-006211 · doc4.xml · derivative · entry 1 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F1 · derivative.expiration_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:36 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006208 · doc4.xml · derivative · entry 2 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. F3 · derivative.exercise_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F3 · derivative.expiration_date: 1/3rd of the shares underlying the RSU vest on January 31, 2021 and 1/12th of the shares underlying the RSU vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:36 UTC |
Barrett Elizabeth A.Chief Executive Officer
|
GrantStock options (right to buy) · Derivative | 45,000 | $0.00 Strike: $29.41 | $0.00 |
DisclosureSEC source: 0001209191-20-006208 · doc4.xml · derivative · entry 1 Barrett Elizabeth A. · CIK 0001764157 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Ordinary Shares · 45,000 shares Expires not disclosed F1 · derivative.exercise_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. F1 · derivative.expiration_date: 1/3rd of the shares underlying the stock option vest on January 31, 2021 and 1/12th of the shares underlying the stock option vest in 8 quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each respective vesting date. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:10 UTC |
Schoenberg MarkChief Medical Officer
|
SaleOrdinary Shares | 322 | $29.15 | $9,386.30 |
DisclosureSEC source: 0001209191-20-005200 · doc4.xml · nonDerivative · entry 2 Schoenberg Mark · CIK 0001763581 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,177 F2 · kind: The transaction reported herein was matchable under Section 16(b) of the Securities and Exchange Act of 1934, to the extent of 322 shares, with the reporting person's purchase of 1,960 ordinary shares of the Issuer at a price of $28.17 per share on November 19, 2019. The reporting person has paid to the Issuer $315.56, representing the full amount of the profit realized in connection with the short-swing transaction. F3 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:15 UTC |
PFREUNDSCHUH PETER P.Chief Financial Officer
|
SaleOrdinary Shares | 667 | $29.28 | $19,529.76 |
DisclosureSEC source: 0001209191-20-005215 · doc4.xml · nonDerivative · entry 2 PFREUNDSCHUH PETER P. · CIK 0001585839 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,438 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
| January 27, 2020 Filed Jan 28, 2020 22:14 UTC |
Mullennix StephenChief Operating Officer
|
SaleOrdinary Shares | 684 | $29.26 | $20,013.84 |
DisclosureSEC source: 0001209191-20-005211 · doc4.xml · nonDerivative · entry 2 Mullennix Stephen · CIK 0001764139 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,665 F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.